Summary
Intuitive Surgical, Inc. (ISRG) reported strong financial performance for the second quarter and first half of 2010, demonstrating significant growth in both revenue and profitability. Total revenue for the second quarter increased by 34.6% year-over-year to $350.7 million, driven by robust sales of both da Vinci Surgical Systems and recurring revenue from instruments, accessories, and services. The company's expanding installed base of da Vinci systems continues to fuel recurring revenue, which now represents a significant portion of total revenue, with growth outpacing system sales. Profitability also saw a marked improvement, with net income for the second quarter rising to $88.7 million, a 42.1% increase from the prior year. This growth was supported by strong gross margins and effective management of operating expenses, despite increased investments in R&D and SG&A to support business expansion. The company's solid cash generation and healthy balance sheet position it well for continued investment in innovation and market expansion.
Financial Highlights
46 data points| Revenue | $350.70M |
| Cost of Revenue | $93.90M |
| Gross Profit | $256.80M |
| R&D Expenses | $28.50M |
| SG&A Expenses | $88.60M |
| Operating Expenses | $117.10M |
| Operating Income | $139.70M |
| Net Income | $88.70M |
| EPS (Basic) | $0.25 |
| EPS (Diluted) | $0.24 |
| Shares Outstanding (Basic) | 353.70M |
| Shares Outstanding (Diluted) | 364.50M |
Key Highlights
- 1Total revenue for Q2 2010 grew 34.6% to $350.7 million, and for the first half of 2010, it grew 51.3% to $679.3 million, indicating strong demand for da Vinci Surgical Systems and related services.
- 2Recurring revenue (instruments, accessories, and service) increased by 33.4% to $182.9 million in Q2 2010 and by 38.7% to $356.2 million in the first half of 2010, highlighting the company's successful 'razor and blades' business model.
- 3The installed base of da Vinci Surgical Systems grew to 1,571 units as of June 30, 2010, up from 1,242 units in the prior year, demonstrating continued market penetration.
- 4Net income for Q2 2010 surged by 42.1% to $88.7 million, translating to diluted earnings per share of $2.19, up from $1.62 in Q2 2009.
- 5The da Vinci Si Surgical System, launched in Q2 2009, represented 82% of system sales in Q2 2010, showing strong market acceptance of the new platform.
- 6Operating cash flow for the first half of 2010 was robust at $291.1 million, significantly exceeding the prior year's $173.1 million, reflecting strong operational performance and efficient working capital management.
- 7The company maintained a strong liquidity position with $1,588.2 million in cash and investments as of June 30, 2010, providing flexibility for future growth and investments.